BTG plc (LON:BTG – Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 840 ($10.91) and traded as high as GBX 840 ($10.91). BTG shares last traded at GBX 840 ($10.91), with a volume of 271,742 shares.
BTG Stock Performance
The firm has a market capitalization of £3.26 billion and a PE ratio of 29.47. The company’s 50 day simple moving average is GBX 840 and its 200-day simple moving average is GBX 840.
About BTG
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Further Reading
- Five stocks we like better than BTG
- Insider Trades May Not Tell You What You Think
- Texas Roadhouse Stock Steering for New Highs This Year
- ETF Screener: Uses and Step-by-Step Guide
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Dividend Capture Strategy: What You Need to Know
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.